Austin, TX (PRWEB) February 18, 2016 -- The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the addition of Barrie Nelson as Vice President, Standards, Terminology and Technical Services. Mr. Nelson has over 18 years of technical and practical experience in the biotech and pharmaceutical industry, coupled with proven knowledge of CDISC and implementation of the CDISC standards for clinical research. He will work with existing CDISC leadership and volunteer teams to guide the future of the way CDISC develops standards, serving an important role in helping CDISC to achieve its strategic goals.
Mr. Nelson brings experience with biostatistical programming, clinical data management, managing and implementing data standards functions, and leading a governance body to oversee the use of data standards. He has led and contributed to many process improvement initiatives with standards at the heart of these projects, with specific goals of cycle time reduction, reduced operational costs and increased quality. Barrie has been a volunteer and leader for CDISC teams since 2003, and spearheaded the development of the Oncology domains for CDISC SDTM.
“We are very pleased to have Barrie join CDISC full-time. He is a respected professional with expertise not only in developing CDISC standards but also implementing them in small biotechnology and large pharmaceutical companies,” said Dr. Rebecca Kush, CDISC CEO. “His proven technical and business leadership will no doubt benefit the CDISC technical teams in working together to achieve CDISC strategic and cross-functional goals toward our vision to inform patient care and safety through higher quality medical research. Ultimately, this will help us all in unlocking cures to benefit patients.”
Prior to joining CDISC, Mr. Nelson was the Senior Director of Clinical Data Management for Onyx Pharmaceuticals, a biopharmaceutical company that develops and markets medicines for the treatment of cancer. At Onyx, Mr. Nelson led the Clinical Data Management function, and served as a member of the Biometrics Leadership Team. He was responsible for budget and resource planning and introduced end-to-end data standards into the Clinical Development organization. Preceding this, Mr. Nelson spent 13 years with Amgen, the world’s largest biopharmaceutical firm, and 4 years with GlaxoSmithKline, building a strong foundation in standards leadership at both organizations.
CDISC is a 501(c)(3) global non-profit charitable organization that streamlines research and enables connections to healthcare through the development of clinical research data standards. CDISC has developed a suite of standards to support clinical research from protocol through analysis and reporting, including therapeutic area specific standards for over 25 disease areas. CDISC standards make it possible for data to speak the same language, empowering simple data collection and private sharing that makes the most of the valuable information offered by patients participating in research studies around the globe. Using CDISC standards from the start of studies enables Smarter Research to Unlock Cures, saving ~60% overall in terms of time and resources to conduct research. CDISC is the patient’s advocate, creating therapeutic area data standards that advance medical product development and various types of clinical research.
Andrea Vadakin, Director of Communications and Public Relations, CDISC, http://www.cdisc.org, +1 (316) 558-0160, [email protected]